SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001493152-21-026354
Filing Date
2021-10-26
Accepted
2021-10-26 17:17:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13da.htm SC 13D/A 40049
  Complete submission text file 0001493152-21-026354.txt   41443
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Subject) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92776 | Film No.: 211349633
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTEC PARENT, INC. 12 HARTOM ST., HAR HOTZVIM JERUSALEM L3 9777512
Business Address
Newman Michael James (Filed by) CIK: 0001876315 (see all company filings)

Type: SC 13D/A